参考文献(References)：
[1] MAYANS L.Nephrolithiasis[J].Primary Care,2019,46(2):203.
[2] ROMERO V,AKPINAR H,ASSIMOS D G.Kidney stones:a global picture of prevalence,incidence,and associated risk factors[J].Nature Reviews Urology,2010,12(2/3):e86.
[3] BASAVARAJ D R,BIYANI C S,BROWNING A J,et al.The role of urinary kidney stone inhibitors and promoters in the pathogenesis of calcium containing renal stones[J].EAU-EBU Update Series,2007,5(3):126.
[4] CHAUDHARY A,SINGLA S K,TANDON C.In vitro evaluation of Terminalia arjuna on calcium phosphate and calcium oxalate crystallization[J].Indian Journal of Pharmaceutical Sciences,2010,72(3):340.
[5] CHUNG M J.Urolithiasis and nephrolithiasis[J].Journal of the American Academy of Physician Assistants,2017,30(9):49.
[6] SCALES C D,Jr,SMITH A C,HANLEY J M,et al.Prevalence of kidney stones in the United States[J].European Urology,2012,62(1):160.
[7] MAGWIRA C A,KULLIN B,LEWANDOWSKI S,et al.Diversity of faecal oxalate-degrading bacteria in black and white South African study groups:insights into understanding the rarity of urolithiasis in the black group[J].Journal of Applied Microbiology,2012,113(2):418.
[8] MIKAMI K,AKAKURA K,TAKEI K,et al.Association of absence of intestinal oxalate degrading bacteria with urinary calcium oxalate stone formation[J].Journal of Applied Microbiology,2003,10(6):293.
[9] LIESKE J C.Probiotics for prevention of urinary stones[J].Annals of Translational Medicine,2017,5(2):29.
[10] LIU M H,DEVLIN J C,HU J Y,et al.Microbial genetic and transcriptional contributions to oxalate degradation by the gut microbiota in health and disease[J].eLife,2021,10:e63642.
[11] SIENER R,BANGEN U,SIDHU H,et al.The role of Oxalo-bacter formigenes colonization in calcium oxalate stone disease[J].Kidney International,2013,83(6):1144.
[12] CAMPIERI C,CAMPIERI M,BERTUZZI V,et al.Reduction of oxaluria after an oral course of lactic acid bacteria at high concentration[J].Kidney International,2001,60(3):1097.
[13] SIENER R,BADE D J,HESSE A,et al.Dietary hyperoxaluria is not reduced by treatment with lactic acid bacteria[J].Journal of Translational Medicine,2013,11(1):306.
[14] HOKAMA S,HONMA Y,TOMA C,et al.Oxalate-degrading Enterococcus faecalis[J].Microbiology and Immunology,2000,44(4):235.
[15] REN Z H,PAN C L,JIANG L Y,et al.Oxalate-degrading capacities of lactic acid bacteria in canine feces[J].Veterinary Microbiology,2011,152(3/4):368.
[16] LIU F R,YU B.Efficient production of reuterin from glycerol by magnetically immobilized Lactobacillus reuteri[J].Applied Microbiology and Biotechnology,2015,99:4659.
[17] LIN X Z,HE Z G,LI W X,et al.Validation of reference genes for real-time quantitative polymerase chain reaction analysis in Lactobacillus plantarum R23 under sulfur dioxide stress conditions[J].Australian Journal of Grape and Wine Research,2018,24(3):390.
[18] LI F R,YUAN L,LU H Z,et al.Deep learning-based Kcat prediction enables improved enzyme-constrained model reconstruction[J].Nature Catalysis,2022,8(5):662.
[19] MANDRILE G,BECK B,ACQUAVIVA C,et al.Genetic assessment in primary hyperoxaluria:why it matters[J].Pediatric Nephrology,2023,38(3):625.
[20] 刘建利，何旭，孙钦飞.降解草酸盐乳酸菌株的筛选及其酸乳发酵特性[J].食品工业科技，2021,42(12):111.
[21] 纪媛媛，马欣莹，步雨珊，等.降解草酸盐益生菌的筛选及其体内功效评价[J].食品与发酵工业，2022,48(13):78.
[22] PUURUNEN M K,VOCKLEY J,SEARLE S L,et al.Safety and pharmacodynamics of an engineered E.coli Nissle for the treatment of phenylketonuria:a first-in-human phase 1/2a study[J].Nature Metabolism,2021,3(8):1125.
[23] ZHAO C M,YANG H,ZHU X J,et al.Oxalate-degrading enzyme recombined lactic acid bacteria strains reduce hyperoxaluria[J].Journal of Urology,2018,113:253.e1.
